跳至主要内容
临床试验/NCT06454123
NCT06454123尚未招募不适用

A Feasibility Study of a Digital Therapeutic for Adults With Recurrent Binge Eating and Obesity

Oui Therapeutics, Inc.0 个研究点目标入组 30 人开始时间: 2024年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
System Usability Sale (SUS)

研究概览

简要总结

The primary objective of this study is to test the feasibility of a digital therapeutic to address comorbid binge eating and obesity in adults.

详细描述

This single-arm, open-label clinical trial will test the feasibility, usability, acceptability, and preliminary efficacy of a digital therapeutic in reducing binge eating and weight in 30 adults with comorbid recurrent binge eating and obesity.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking male or female patients, 18-70 years
  • Patients with recurrent binge eating (≥12 episodes in 3 months) and obesity (BMI ≥30)
  • Understand written and spoken English
  • Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
  • Willing and able to complete enrollment procedures
  • Able to understand the nature of the study and provide written informed consent

排除标准

  • Patients with active psychosis
  • Patients who are acutely intoxicated at the time of enrollment
  • Currently enrolled in other treatment studies for the symptoms and behaviors targeted
  • Patients who are cognitively impaired
  • Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the digital therapeutic

结局指标

主要结局

System Usability Sale (SUS)

时间窗: Week 12

The SUS and a semi-structured user feedback interview will be utilized to systematically capture usability and acceptability.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验